Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Scinai Immunotherapeutics Ltd. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/30/2024 | Q3 2024 | N/A | $12.39 | N/A | N/A | $168,000 |
| 09/09/2024 | Q2 2024 | N/A | -$3.64 | N/A | N/A | $284,000 |
| 03/31/2024 | Q1 2024 | N/A | -$4.26 | N/A | N/A | $0 |
| 12/31/2023 | Q4 2023 | N/A | -$9.60 | N/A | N/A | $0 |
| 09/30/2023 | Q3 2023 | N/A | $6.62 | N/A | N/A | $0 |
| 06/30/2023 | Q2 2023 | N/A | -$11.13 | N/A | N/A | $0 |
| 03/31/2023 | Q1 2023 | N/A | -$10.85 | N/A | N/A | $0 |
| 12/31/2022 | Q4 2022 | N/A | -$11.70 | N/A | N/A | $0 |
| 09/30/2022 | Q3 2022 | -$1.00 | $5.63 | 6.63 | N/A | $0 |
| 06/30/2022 | Q2 2022 | -$1.00 | -$15.98 | -14.98 | N/A | $0 |
| 03/31/2022 | Q1 2022 | N/A | -$13.29 | N/A | N/A | $0 |
| 12/31/2021 | Q4 2021 | N/A | $8.21 | N/A | N/A | $0 |
| 09/30/2021 | Q3 2021 | N/A | -$19.58 | N/A | N/A | $0 |
| 06/30/2021 | Q2 2021 | N/A | -$25.67 | N/A | N/A | $0 |
| 03/31/2021 | Q1 2021 | N/A | -$18.45 | N/A | N/A | $0 |
| 12/31/2020 | Q4 2020 | N/A | -$38.03 | N/A | N/A | $0 |
| 09/30/2020 | Q3 2020 | N/A | $140.08 | N/A | N/A | $0 |
| 06/30/2020 | Q2 2020 | N/A | -$111.79 | N/A | N/A | $0 |
| 03/31/2020 | Q1 2020 | N/A | -$10.20 | N/A | N/A | $0 |
| 12/31/2019 | Q4 2019 | N/A | -$114.75 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Scinai Immunotherapeutics Ltd. Earnings: FAQ's
Scinai Immunotherapeutics Ltd. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 29th, 2025 based offlast year's report dates.
In the previous quarter, Scinai Immunotherapeutics Ltd. (:SCNI) reported $12 earnings per share (EPS) to beat the analysts' consensus estimate of $-6.2 by $18.2.
The conference call for Scinai Immunotherapeutics Ltd.'s latest earnings report can be listened to online.
The conference call transcript for Scinai Immunotherapeutics Ltd.'s latest earnings report can be read online.
Scinai Immunotherapeutics Ltd. (:SCNI) has a recorded net income of $-6,500,000.Scinai Immunotherapeutics Ltd. has generated $-16.64 earnings per share over the last four quarters.
Scinai Immunotherapeutics Ltd. (:SCNI) has a price-to-earnings ratio of 0 and price/earnings-to-growth ratio is 0.